COSMOS Pharmaceutical Balance Sheet Health
Financial Health criteria checks 5/6
COSMOS Pharmaceutical has a total shareholder equity of ¥200.2B and total debt of ¥3.6B, which brings its debt-to-equity ratio to 1.8%. Its total assets and total liabilities are ¥378.9B and ¥178.7B respectively. COSMOS Pharmaceutical's EBIT is ¥30.2B making its interest coverage ratio -15101.5. It has cash and short-term investments of ¥29.7B.
Key information
1.8%
Debt to equity ratio
JP¥3.65b
Debt
Interest coverage ratio | -15101.5x |
Cash | JP¥29.67b |
Equity | JP¥200.23b |
Total liabilities | JP¥178.66b |
Total assets | JP¥378.89b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: CSMY.F's short term assets (¥116.4B) do not cover its short term liabilities (¥168.6B).
Long Term Liabilities: CSMY.F's short term assets (¥116.4B) exceed its long term liabilities (¥10.0B).
Debt to Equity History and Analysis
Debt Level: CSMY.F has more cash than its total debt.
Reducing Debt: CSMY.F's debt to equity ratio has reduced from 14% to 1.8% over the past 5 years.
Debt Coverage: CSMY.F's debt is well covered by operating cash flow (1150.3%).
Interest Coverage: CSMY.F earns more interest than it pays, so coverage of interest payments is not a concern.